Early estimates of nirsevimab immunoprophylaxis effectiveness against hospital admission for respiratory syncytial virus lower respiratory tract infections in infants, Spain, October 2023 to January 2024.

Autor: López-Lacort M; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; These authors contributed equally to this article and share first authorship.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Muñoz-Quiles C; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; These authors contributed equally to this article and share first authorship.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Mira-Iglesias A; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., López-Labrador FX; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.; Virology Laboratory, Fisabio-Public Health, Valencia, Spain.; Department of Microbiology and Ecology, Medical School, University of Valencia, Valencia, Spain., Mengual-Chuliá B; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.; Virology Laboratory, Fisabio-Public Health, Valencia, Spain., Fernández-García C; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain., Carballido-Fernández M; Hospital General Universitario de Castellón, Castellón, Spain.; Medicine Department, Universidad CEU Cardenal Herrera, Castellón de la Plana, Spain., Pineda-Caplliure A; Hospital Universitario Dr. Peset, Valencia, Spain., Mollar-Maseres J; Hospital Universitario La Fe, Valencia, Spain., Shalabi Benavent M; Hospital Marina Baixa, Alicante, Spain., Sanz-Herrero F; Hospital General Universitario, Valencia, Spain., Zornoza-Moreno M; Murcia Health Council, Murcia, Spain., Pérez-Martín JJ; Murcia Health Council, Murcia, Spain., Alfayate-Miguelez S; Murcia Health Council, Murcia, Spain., Pérez Crespo R; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Bastida Sánchez E; Hospital Clínico Universitario Virgen de la Arrixaca, Murcia, Spain., Menasalvas-Ruiz AI; Hospital General Universitario Santa Lucía, Murcia, Spain., Téllez-González MC; Hospital General Universitario Santa Lucía, Murcia, Spain., Esquiva Soto S; Hospital General Universitario Santa Lucía, Murcia, Spain., Del Toro Saravia C; Hospital Rafael Méndez, Murcia, Spain., Sanz-Muñoz I; National Influenza Centre, Valladolid, Spain., Eiros JM; National Influenza Centre, Valladolid, Spain., Matías Del Pozo V; Hospital Clínico, Valladolid, Spain., Toquero-Asensi M; Hospital Clínico, Valladolid, Spain., Pastor-Villalba E; Dirección General de Salud Pública, Valencia, Spain., Lluch-Rodrigo JA; Dirección General de Salud Pública, Valencia, Spain., Díez-Domingo J; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; Catholic University of Valencia, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain., Orrico-Sánchez A; Vaccine Research Department, Fisabio-Public Health, Valencia, Spain.; Catholic University of Valencia, Valencia, Spain.; CIBERESP, Instituto de Salud Carlos III, Madrid, Spain.

Publikováno v: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin [Euro Surveill] 2024 Feb; Vol. 29 (6).